[


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
10 2021
Historique:
received: 12 12 2020
accepted: 07 03 2021
pubmed: 28 3 2021
medline: 21 10 2021
entrez: 27 3 2021
Statut: ppublish

Résumé

To test the performances of native and tumour to liver ratio (TLR) radiomic features extracted from pre-treatment 2-[ One hundred fifty-eight patients with LACC from multiple centers were retrospectively included in the study. Tumours were segmented using the Fuzzy Local Adaptive Bayesian (FLAB) algorithm. Radiomic features were extracted from the tumours and from regions drawn over the normal liver. Cox proportional hazard model was used to test statistical significance of clinical and radiomic features. Fivefold cross validation was used to tune the number of features. Seven different feature selection methods and four classifiers were tested. The models with the selected features were trained using bootstrapping and tested in data from each scanner independently. Reproducibility of radiomics features, clinical data added value and effect of ComBat-based harmonisation were evaluated across scanners. After a median follow-up of 23 months, 29% of the patients recurred. No individual radiomic or clinical features were significantly associated with cancer recurrence. The best model was obtained using 10 TLR features combined with clinical information. The area under the curve (AUC), F [

Identifiants

pubmed: 33772334
doi: 10.1007/s00259-021-05303-5
pii: 10.1007/s00259-021-05303-5
pmc: PMC8440288
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3432-3443

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Int J Gynecol Cancer. 2018 Mar;28(3):575-580
pubmed: 29372911
Semin Nucl Med. 2020 Nov;50(6):532-540
pubmed: 33059822
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):864-877
pubmed: 30535746
IEEE Trans Med Imaging. 2009 Jun;28(6):881-93
pubmed: 19150782
Neuroimage. 2017 Nov 1;161:149-170
pubmed: 28826946
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1551-1559
pubmed: 30729273
Virchows Arch. 2018 Jun;472(6):919-936
pubmed: 29725757
Sci Rep. 2017 Oct 16;7(1):13206
pubmed: 29038455
IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1226-38
pubmed: 16119262
Radiat Oncol. 2018 Oct 5;13(1):197
pubmed: 30290849
Phys Med Biol. 2018 May 02;63(9):095007
pubmed: 29616661
Int J Gynecol Cancer. 2020 Nov;30(11):1705-1712
pubmed: 33033165
Sci Rep. 2015 Aug 17;5:13087
pubmed: 26278466
Nucl Med Commun. 2019 Mar;40(3):219-227
pubmed: 30585896
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Radiother Oncol. 2012 Feb;102(2):239-45
pubmed: 22098794
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Sci Rep. 2019 Jul 4;9(1):9649
pubmed: 31273242
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2812-2813
pubmed: 31696246
Med Image Anal. 2018 Feb;44:177-195
pubmed: 29268169
Clin Nucl Med. 2016 Jan;41(1):34-40
pubmed: 26505856
Phys Med. 2018 Feb;46:180-188
pubmed: 29475772
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
Phys Med. 2018 Jun;50:66-74
pubmed: 29891096
Ann Surg. 2021 Dec 1;274(6):e1153-e1161
pubmed: 31913871
Med Phys. 2017 Mar;44(3):1050-1062
pubmed: 28112418
PLoS One. 2019 Apr 19;14(4):e0215465
pubmed: 31002689
Ann Nucl Med. 2017 Nov;31(9):678-685
pubmed: 28815452
J Appl Clin Med Phys. 2017 Nov;18(6):32-48
pubmed: 28891217
Sci Rep. 2019 May 6;9(1):6994
pubmed: 31061433
Phys Med Biol. 2019 Apr 12;64(8):085019
pubmed: 30818303
J Magn Reson Imaging. 2018 May;47(5):1388-1396
pubmed: 29044908
PLoS One. 2019 Jun 3;14(6):e0217536
pubmed: 31158263
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2656-2672
pubmed: 31214791
Clin Cancer Res. 2019 Jun 1;25(11):3266-3275
pubmed: 31010833
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Ann Oncol. 2017 Jul 1;28(suppl_4):iv72-iv83
pubmed: 28881916
Sci Rep. 2015 Aug 05;5:11075
pubmed: 26242464
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
J Nucl Med. 2004 May;45(5):784-8
pubmed: 15136627
Eur Radiol. 2019 Dec;29(12):6741-6749
pubmed: 31134366
Eur Radiol. 2017 Nov;27(11):4498-4509
pubmed: 28567548
Sci Rep. 2020 Jan 15;10(1):369
pubmed: 31941949
Eur J Clin Invest. 2015 Feb;45(2):204-14
pubmed: 25623047
Eur J Radiol. 2017 Dec;97:8-15
pubmed: 29153372
Sci Rep. 2020 Jun 24;10(1):10248
pubmed: 32581221
Neuroimage. 2020 Oct 15;220:117127
pubmed: 32634595
Eur J Nucl Med Mol Imaging. 2018 May;45(5):768-786
pubmed: 29222685
Semin Nucl Med. 2019 Nov;49(6):461-470
pubmed: 31630730
Med Phys. 2018 Jul;45(7):3449-3459
pubmed: 29763967
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
J Nucl Med. 2018 Aug;59(8):1321-1328
pubmed: 29301932

Auteurs

Marta Ferreira (M)

GIGA-CRC in vivo Imaging, University of Liège, GIGA, Avenue de l'Hôpital 11, 4000, Liege, Belgium. m.Ferreira@student.uliege.be.

Pierre Lovinfosse (P)

Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.

Johanne Hermesse (J)

Department of Radiation Oncology, Liège University Hospital, Liège, Belgium.

Marjolein Decuypere (M)

Division of Oncological Gynecology, University Hospital of Liège, Liège, Belgium.

Caroline Rousseau (C)

Université de Nantes, CNRS, Inserm, CRCINA, F-44000, Nantes, France.
ICO René Gauducheau, F-44800, Saint-Herblain, France.

François Lucia (F)

Radiation Oncology Department, University Hospital, Brest, France.
LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Ulrike Schick (U)

Radiation Oncology Department, University Hospital, Brest, France.
LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Caroline Reinhold (C)

Department of Radiology, McGill University Health Centre (MUHC), Montreal, Canada.

Philippe Robin (P)

Department of Nuclear Medicine and EA3878, Brest University Hospital, University of Brest, Brest, France.

Mathieu Hatt (M)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Dimitris Visvikis (D)

LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.

Claire Bernard (C)

Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.

Ralph T H Leijenaar (RTH)

Oncoradiomics SA, Clos Chanmurly 13, 4000, Liège, Belgium.
The-D Lab, Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.

Frédéric Kridelka (F)

Division of Oncological Gynecology, University Hospital of Liège, Liège, Belgium.

Philippe Lambin (P)

The-D Lab, Precision Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands.
Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Patrick E Meyer (PE)

Bioinformatics and Systems Biology Lab, University of Liège, Liège, Belgium.

Roland Hustinx (R)

GIGA-CRC in vivo Imaging, University of Liège, GIGA, Avenue de l'Hôpital 11, 4000, Liege, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH